Michel D'Incan

7PUBLICATIONS
40CO-AUTHORS
Molecular targetsToxicology (incl. clinical toxicology)Haematological tumoursTumour immunologyMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 03, 2025
Targeting Melanin Heterogeneity in Metastatic Melanoma: A Dual-Tumour Mouse Melanoma Model.

Marine Delmas, Benjamin Chaussin, Nathan Harismendy

|Jun 26, 2021
International multicentre observational study to assess the efficacy and safety of a 0·5 mg kg-1 per day starting dose of oral corticosteroids to treat bullous pemphigoid.

V Hébert, S Bastos, K Drenovska

|Apr 03, 2021
Efficacy of Targeted Radionuclide Therapy Using [131I]ICF01012 in 3D Pigmented BRAF- and NRAS-Mutant Melanoma Models and In Vivo NRAS-Mutant Melanoma.

Hussein Akil, Mercedes Quintana, Jérémy H Raymond

|Nov 01, 2020
Epidemiological changes in cutaneous lymphomas: an analysis of 8593 patients from the French Cutaneous Lymphoma Registry.

G Dobos, A de Masson, C Ram-Wolff

|May 25, 2020
Immune checkpoint inhibitors reverse tolerogenic mechanisms induced by melanoma targeted radionuclide therapy.

Jacques Rouanet, Valentin Benboubker, Hussein Akil

|Jan 18, 2019
Methylisothiazolinone allergic contact dermatitis: Assessment of relapses in 139 patients after avoidance advice.

Pauline Bouschon, Julie Waton, Bruno Pereira

Pageof 2

Frequent Collaborators

3 joint publications

S Ingen-Housz-Oro

3 joint publications

Sophie Besse

3 joint publications

Jacques Rouanet

2 joint publications

M Beylot-Barry